View Future GrowthRibbon Acquisition 과거 순이익 실적과거 기준 점검 1/6Ribbon Acquisition의 연간 평균 수익은 366.6%였으며, Capital Markets 산업의 수익은 연간 5.8% 증가했습니다.핵심 정보366.57%순이익 성장률829.06%주당순이익(EPS) 성장률Capital Markets 산업 성장률10.26%매출 성장률n/a자기자본이익률n/a순이익률n/a최근 순이익 업데이트31 Mar 2026최근 과거 실적 업데이트업데이트 없음모든 업데이트 보기Recent updatesNew Risk • Jul 02New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Currently running at an operating cash loss. This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Shares are highly illiquid. Negative equity (-US$355k). High level of non-cash earnings (1,727% accrual ratio). Revenue is less than US$1m. Minor Risks Less than 3 years of financial data is available. Market cap is less than US$100m (US$51.6m market cap).New Risk • Apr 09New major risk - Negative shareholders equityThe company has negative equity. Total equity: -US$344k This is considered a major risk. Being in negative equity means that the company's liabilities exceed its assets, meaning it owes more to creditors than it has in owned assets. While this doesn't mean the company is about to collapse, in the long-term, this is unsustainable. The company may have issues meeting financial obligations, is at risk of becoming insolvent and may have difficulty raising capital, especially more debt, if needed. Currently, the following risks have been identified for the company: Major Risks Negative equity (-US$344k). Revenue is less than US$1m. Minor Risks Less than 3 years of financial data is available. Large one-off items impacting financial results. Market cap is less than US$100m (US$50.4m market cap).New Risk • Apr 02New major risk - Financial data availabilityThe company's latest financial reports are more than a year old. Last reported fiscal period ended December 2024. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported December 2024 fiscal period end). Revenue is less than US$1m. Minor Risk Market cap is less than US$100m (US$63.7m market cap).공고 • Jul 02DR.C Medical Medicine Co., Ltd. entered into a business combination agreement to acquire Ribbon Acquisition Corp. (NasdaqCM:RIBB) in a reverse merger transaction for approximately $350 million.DR.C Medical Medicine Co., Ltd. entered into a business combination agreement to acquire Ribbon Acquisition Corp. (NasdaqCM:RIBB) in a reverse merger transaction for approximately $350 million on June 30, 2025. Current DR.C Medical Medicine Co., Ltd. shareholders will retain 100% of their equity and will continue to own approximately 82.91% of the combined company on a pro forma basis, assuming no redemptions by Ribbon Acquisition Corp shareholder. Combined company to have an implied initial pro forma equity value of approximately $422.15 Million, assuming no redemptions and the transaction is expected to deliver cash proceeds of around $50.42 Million to DR.C Medical Medicine Co., Ltd. assuming no redemptions to fund DR.C Medical Medicine Co., Ltd. business and operations, which include devices’ clinical trial and certification. A.G.P. / Alliance Global Partners, LLC acted as financial advisor for Ribbon Acquisition Corp. Geneva Capital Group acted as financial advisor for DR.C Medical Medicine Co., Ltd. The Ross Law Group, LLC acted as legal advisor for DR.C Medical Medicine Co., Ltd. Celine & Partners, PLLC acted as legal advisor for Ribbon Acquisition Corp.공고 • Apr 03Ribbon Acquisition Corp. announced delayed annual 10-K filingOn 04/01/2025, Ribbon Acquisition Corp. announced that they will be unable to file their next 10-K by the deadline required by the SEC.매출 및 비용 세부 내역Ribbon Acquisition가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이NasdaqCM:RIBB 매출, 비용 및 순이익 (USD Millions)날짜매출순이익일반관리비연구개발비31 Mar 26011031 Dec 250110양질의 수익: RIBB의 비현금 수익 수준이 높습니다.이익 마진 증가: 지난 1년 동안 RIBB의 이익률이 개선되었는지 판단하기에 데이터가 부족합니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: RIBB은 상장된 지 3년이 되지 않아 지난 5년간 전년 대비 수익 증가율이 긍정적인지 확인할 수 없습니다.성장 가속화: RIBB은 상장된 지 3년이 되지 않아 지난 해 수익 성장률을 5년 평균과 비교할 수 없습니다.수익 대 산업: RIBB의 지난 1년 수익 증가율(366.6%)은 Capital Markets 업계의 35.9%를 상회했습니다.자기자본이익률높은 ROE: RIBB의 부채가 자산을 초과하여 자본 수익률을 계산하기 어렵습니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YDiversified-financials 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/07/27 22:27종가2026/07/27 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Ribbon Acquisition Corp.는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
New Risk • Jul 02New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Currently running at an operating cash loss. This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Shares are highly illiquid. Negative equity (-US$355k). High level of non-cash earnings (1,727% accrual ratio). Revenue is less than US$1m. Minor Risks Less than 3 years of financial data is available. Market cap is less than US$100m (US$51.6m market cap).
New Risk • Apr 09New major risk - Negative shareholders equityThe company has negative equity. Total equity: -US$344k This is considered a major risk. Being in negative equity means that the company's liabilities exceed its assets, meaning it owes more to creditors than it has in owned assets. While this doesn't mean the company is about to collapse, in the long-term, this is unsustainable. The company may have issues meeting financial obligations, is at risk of becoming insolvent and may have difficulty raising capital, especially more debt, if needed. Currently, the following risks have been identified for the company: Major Risks Negative equity (-US$344k). Revenue is less than US$1m. Minor Risks Less than 3 years of financial data is available. Large one-off items impacting financial results. Market cap is less than US$100m (US$50.4m market cap).
New Risk • Apr 02New major risk - Financial data availabilityThe company's latest financial reports are more than a year old. Last reported fiscal period ended December 2024. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported December 2024 fiscal period end). Revenue is less than US$1m. Minor Risk Market cap is less than US$100m (US$63.7m market cap).
공고 • Jul 02DR.C Medical Medicine Co., Ltd. entered into a business combination agreement to acquire Ribbon Acquisition Corp. (NasdaqCM:RIBB) in a reverse merger transaction for approximately $350 million.DR.C Medical Medicine Co., Ltd. entered into a business combination agreement to acquire Ribbon Acquisition Corp. (NasdaqCM:RIBB) in a reverse merger transaction for approximately $350 million on June 30, 2025. Current DR.C Medical Medicine Co., Ltd. shareholders will retain 100% of their equity and will continue to own approximately 82.91% of the combined company on a pro forma basis, assuming no redemptions by Ribbon Acquisition Corp shareholder. Combined company to have an implied initial pro forma equity value of approximately $422.15 Million, assuming no redemptions and the transaction is expected to deliver cash proceeds of around $50.42 Million to DR.C Medical Medicine Co., Ltd. assuming no redemptions to fund DR.C Medical Medicine Co., Ltd. business and operations, which include devices’ clinical trial and certification. A.G.P. / Alliance Global Partners, LLC acted as financial advisor for Ribbon Acquisition Corp. Geneva Capital Group acted as financial advisor for DR.C Medical Medicine Co., Ltd. The Ross Law Group, LLC acted as legal advisor for DR.C Medical Medicine Co., Ltd. Celine & Partners, PLLC acted as legal advisor for Ribbon Acquisition Corp.
공고 • Apr 03Ribbon Acquisition Corp. announced delayed annual 10-K filingOn 04/01/2025, Ribbon Acquisition Corp. announced that they will be unable to file their next 10-K by the deadline required by the SEC.